CASI-Pharmaceuticals-凯信远达's Zone-32BTree

CASI-Pharmaceuticals-凯信远达

PractitionerLv2

CASI Pharmaceuticals, Inc. is a NASDAQ-listed biopharmaceutical company.

China

CASIPHARMACEUTICALS.COM

Established on 8/3/2012

Follow

Friend

ZONE FEED10 CONTRIBUTION10

Videos3

Columns7

Their column

by time

CASI And Cleave Therapeutics Announce Clinical Trial Application Approval For CB-5339 In Patients With Multiple Myeloma In China

1,900

2023-5-12

CASI Pharmaceuticals’ Partner Juventas Announces New Drug Application For CNCT19 Accepted By China National Medical Products Administration

1,440

2023-5-12

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS

1,696

2023-5-12

CASI制药合作伙伴BIOINVENT于 ASH 2021公布BI-1206最新临床研究成果

1,377

2023-5-12

CASI合作伙伴BIOINVENT宣布BI-1206获美国FDA孤儿药资格认定治疗滤泡性淋巴瘤

1,016

2023-5-12

迈入新生，维宁稳行，预见未来，亿路向前

1,253

2023-5-12

CASI制药CNCT19细胞注射液获美国FDA孤儿药资格认定正式开启全球化征程

1,305

2023-5-11

Reward

Total

Received people's reward this month

Achievement

Views

15.1K

Likes

836

Favorites

12

Silver pens

113